Home / Digestive tract and metabolism / Insulin Glulisine
ATC A10AB06 · Insulins and Analogues for Injection, Fast-Acting · updated 4 Nov 2026
Insulin Glulisine shortage
As of 4 Nov 2026, Insulin Glulisine has a reported shortage in 1 of the 16 countries we track (Canada), covering 1 product from 1 company.
Is there an Insulin Glulisine shortage?
Yes. As of 4 Nov 2026, Insulin Glulisine is reported short in 1 of the 16 countries we track: Canada. No company has given a return date. New since 5 Oct 2026: Canada.
Timeline
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Sanofi SAN · Euronext Paris
Compared with similar medicines
ATC group A10AB · Insulins and Analogues for Injection, Fast-ActingAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APIDRA (3ml CARTRIDGE) | SANOFI-AVENTIS CANADA INC | 2 Nov 2026 | not given | Other Other (Please describe in comments) |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.
Questions
Is there an Insulin Glulisine shortage?
Yes. As of 4 Nov 2026, Insulin Glulisine is reported short in 1 of the 16 countries we track: Canada. No company has given a return date. New since 5 Oct 2026: Canada.
When will Insulin Glulisine be back in stock?
No return date has been given; Canada: no date given. These are company estimates reported to each authority.
Why is Insulin Glulisine in short supply?
The most common reason reported is: other. Reasons by product are listed in the table below.
Which companies have Insulin Glulisine shortages?
Sanofi.